Advance Publication of Interim Report January-September 2021
GOTHENBURG, SE / ACCESSWIRE / October 5, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)For administrative reasons, XVIVO Perfusion (publ)...
Year: 2021
iOmx Therapeutics Raises EUR 65 million in Series B Round
Financing round with top-tier life science venture capitalists, led by Athos Service and MIG Capital, joined by existing shareholdersThe new...
New Data Showing the Potential of the NeuroRestore Project in Depression Presented at ECNP 2021 Conference
STOCKHOLM, SE / ACCESSWIRE / October 5, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company...
Mars Pledges Fresh Climate Action to Achieve Net Zero Emissions Across Full Value Chain
The company sets new science-based climate target to achieve net zero greenhouse gas (GHG) emissions across its full value chain...
Ann Arbor SPARK’s FastTrack Awards Honor 18 Companies for Significant, Consistent Growth
ANN ARBOR, Mich.--(BUSINESS WIRE)--Kicking off a2Tech360, Ann Arbor SPARK presented its 23nd annual FastTrack Awards to 18 companies located in...
Asensus Surgical Announces Board Chair Transition
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between...
CONMED Corporation to Announce Third Quarter 2021 Financial Results on October 27, 2021
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2021 after...
Diagu Announces $2 Million Seed Round for Pioneering Medical Technology
SAN DIEGO, CA / ACCESSWIRE / October 4, 2021 / Diagu, a MedTech startup, is building the next generation of...
Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain
Calgary, Alberta--(Newsfile Corp. - October 4, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased...
Advanced Proteome Therapeutics Technology Featured in Oral Presentation at the World Molecular Imaging Congress
Vancouver, British Columbia--(Newsfile Corp. - October 4, 2021) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E8) ("APC" or the "Company"), is...
CTI Announces New Lab Partnership With BioAgilytix
Alliance to strengthen both companies' ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle...
Qventus Introduces New Perioperative Solution to Increase Prime Time Utilization and Grow Case Volume
MOUNTAIN VIEW, Calif., Oct. 4, 2021 /PRNewswire/ -- Qventus, the leader in real-time automation for care operations, today introduced a...
Cann American Corp. Elaborates On Reg A Cancellation and Provides Shareholder Update
CLOVERDALE, CA / ACCESSWIRE / October 4, 2021 / Cann American Corp. (OTC PINK:CNNA), the "Company", is pleased to provide...
27th Annual BIO-Europe(R) Digital to Bring Together 3,500 Life Science Leaders
MUNICH, GERMANY / ACCESSWIRE / October 4, 2021 / The 27th annual BIO-Europe(R) global life sciences partnering event will be...
The First Delivery of Dosell Consumer is Sent to Apoteket AB for Start of Sales
STOCKHOLM, SE / ACCESSWIRE / October 4, 2021 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) announces that Dosell Consumer will...
Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021
Chief Medical Officer will join expert panel on data and tech in psychedelic-assisted psychotherapyTORONTO, ON / ACCESSWIRE / October 4,...
9 Meters Biopharma, Inc. Appoints Samantha Ventimiglia to Board of Directors
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
Nutriband Inc.’s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
ORLANDO, FL / ACCESSWIRE / October 4, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical...
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...
ContraFect’s New Phase 2 Exebacase Data Presented at IDWeekTM Demonstrates Rapid Symptom Resolution Among Patients with Staphylococcus aureus Bacteremia
YONKERS, New York, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a late clinical-stage biotechnology company focused on the...